JP2016529213A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529213A5 JP2016529213A5 JP2016522133A JP2016522133A JP2016529213A5 JP 2016529213 A5 JP2016529213 A5 JP 2016529213A5 JP 2016522133 A JP2016522133 A JP 2016522133A JP 2016522133 A JP2016522133 A JP 2016522133A JP 2016529213 A5 JP2016529213 A5 JP 2016529213A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- seq
- set forth
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013902377A AU2013902377A0 (en) | 2013-06-27 | A super-agonist monoclonal antibody to human IL-21 and its application in immunomodulation | |
| AU2013902377 | 2013-06-27 | ||
| PCT/AU2014/000673 WO2014205501A1 (en) | 2013-06-27 | 2014-06-27 | Il-21 binding proteins and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016529213A JP2016529213A (ja) | 2016-09-23 |
| JP2016529213A5 true JP2016529213A5 (enExample) | 2018-11-01 |
| JP6563389B2 JP6563389B2 (ja) | 2019-08-21 |
Family
ID=52140667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016522133A Expired - Fee Related JP6563389B2 (ja) | 2013-06-27 | 2014-06-27 | Ｉｌ−２１結合タンパク質及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10077301B2 (enExample) |
| EP (1) | EP3013858B1 (enExample) |
| JP (1) | JP6563389B2 (enExample) |
| CN (1) | CN105579470B (enExample) |
| AU (1) | AU2014302028B2 (enExample) |
| CA (1) | CA2915882C (enExample) |
| ES (1) | ES2898650T3 (enExample) |
| WO (1) | WO2014205501A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014205501A1 (en) | 2013-06-27 | 2014-12-31 | Monash University | Il-21 binding proteins and uses thereof |
| EP3233120A4 (en) | 2014-12-19 | 2018-05-30 | Monash University | Il-21 antibodies |
| RU2741802C2 (ru) | 2016-01-12 | 2021-01-28 | Нэшнл Юниверсити Корпорейшн Тиба Юниверсити | АНТИТЕЛО К Myl9 |
| WO2019032628A1 (en) | 2017-08-07 | 2019-02-14 | The Regents Of The University Of California | GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS |
| WO2022117569A1 (en) | 2020-12-02 | 2022-06-09 | Oncurious Nv | A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer |
| TW202241935A (zh) | 2020-12-18 | 2022-11-01 | 美商世紀治療股份有限公司 | 具有可調適受體專一性之嵌合抗原受體系統 |
| CN119290543B (zh) * | 2024-12-13 | 2025-03-21 | 天津医科大学总医院空港医院 | 一种同时检测淋巴组织中il-6、il-21与t细胞cd4表面分子的试剂盒及方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309636B1 (en) * | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| EP1786463A4 (en) | 2004-03-26 | 2009-05-20 | Human Genome Sciences Inc | ANTIBODY AGAINST NOGO RECEPTOR |
| EP1753458A4 (en) * | 2004-05-19 | 2009-07-22 | Wyeth Corp | MODULATION OF IMMUNOGLOBULIN PRODUCTION AND ATOPIC DISORDERS |
| ITRM20040586A1 (it) | 2004-11-29 | 2005-02-28 | Giuliani Spa | Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico. |
| WO2006105538A2 (en) * | 2005-03-31 | 2006-10-05 | Centocor, Inc. | Methods and compositions for treating il-21 related pathologies |
| US20070122413A1 (en) * | 2005-11-28 | 2007-05-31 | Sivakumar Pallavur V | Il-21 antagonists |
| WO2007109742A2 (en) | 2006-03-21 | 2007-09-27 | Weaver David T | Methods for humanizing antibodies and humanized antibodies made thereby |
| WO2008112543A2 (en) * | 2007-03-09 | 2008-09-18 | Wyeth | Rat, rabbit, and cynomolgus monkey il-21 and il-22 nucleotide and polypeptide sequences |
| EP2217268B1 (en) | 2007-12-07 | 2016-05-04 | ZymoGenetics, Inc. | Anti-human il-21 monoclonal antibodies |
| WO2009100035A2 (en) * | 2008-02-01 | 2009-08-13 | Wyeth | Interleukin-21 (il-21) and il-21 receptor (il-21r) modulation of regulatory t cells and forkhead box p3 (foxp3) |
| WO2012164021A1 (en) * | 2011-05-31 | 2012-12-06 | Novo Nordisk A/S | Il-21 epitope and il-21 ligands |
| WO2014205501A1 (en) | 2013-06-27 | 2014-12-31 | Monash University | Il-21 binding proteins and uses thereof |
-
2014
- 2014-06-27 WO PCT/AU2014/000673 patent/WO2014205501A1/en not_active Ceased
- 2014-06-27 AU AU2014302028A patent/AU2014302028B2/en not_active Ceased
- 2014-06-27 US US14/392,256 patent/US10077301B2/en active Active
- 2014-06-27 CN CN201480037182.8A patent/CN105579470B/zh not_active Expired - Fee Related
- 2014-06-27 JP JP2016522133A patent/JP6563389B2/ja not_active Expired - Fee Related
- 2014-06-27 EP EP14817437.8A patent/EP3013858B1/en active Active
- 2014-06-27 ES ES14817437T patent/ES2898650T3/es active Active
- 2014-06-27 CA CA2915882A patent/CA2915882C/en active Active
-
2018
- 2018-08-13 US US16/101,976 patent/US10787510B2/en not_active Expired - Fee Related
-
2020
- 2020-07-23 US US16/937,121 patent/US20210002362A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI821474B (zh) | Ｃｄ３抗體及其藥物用途 | |
| CN112969476B (zh) | 多特异性蛋白分子 | |
| JP2020525032A5 (enExample) | ||
| JP2020508655A5 (enExample) | ||
| JP2020063262A5 (enExample) | ||
| JP2017504578A5 (enExample) | ||
| JP2021530251A5 (enExample) | ||
| CN111417653A (zh) | Cd47抗原结合分子 | |
| JP2020533311A5 (ja) | ＮＫＧ２Ｄ、ＣＤ１６およびＮｅｃｔｉｎ４に結合するタンパク質 | |
| JP2018517431A5 (enExample) | ||
| RU2015144098A (ru) | Четырехвалентные биспецифические антитела | |
| JP2020531043A (ja) | 抗４−１ｂｂ抗体とその作製及び使用方法 | |
| JP2017535257A5 (enExample) | ||
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| JP2018527919A5 (enExample) | ||
| JP2019512207A5 (enExample) | ||
| JP2014518615A5 (enExample) | ||
| JP2015163068A5 (enExample) | ||
| JP2013545455A5 (enExample) | ||
| JP2022533538A5 (enExample) | ||
| JP2023550998A5 (enExample) | ||
| JP2013506428A5 (enExample) | ||
| JP2012501670A5 (enExample) | ||
| RU2013125459A (ru) | АНТИТЕЛА ПРОТИВ БЕЛКА РЕЦЕПТОРА c-Met | |
| JP2017537082A5 (enExample) |